Categorías

Eden: Eden raises $10M to advance AI radiology

Por

Eden Experts

Eden, the leading medical technology company in Latin America, announced an unprecedented financing round of over $10 million in healthtech, led by Sierra Ventures in Silicon Valley. This investment will boost Eden's mission to transform healthcare through artificial intelligence and technological innovation, with a particular focus on its revolutionary new product, Eden Portal.

‍

A future without deadly diseases

"At Eden, we believe that healthcare technology has the potential to make diseases like cancer non-lethal," stated Julian Ríos Cantú, co-founder and CEO of Eden. "However, this mission cannot be achieved alone. That is why we are excited to partner with world-class investors like Sierra Ventures, Dalus, Jack Altman of Alt Capital, Liquid 2, MBX, YCombinator, Meridian Ventures, Khosla, Kaszek, Hummingbird and ID345 to bring our vision to reality."

‍

Introducing Eden Portal: The ultimate medical portal

With this new round of funding, Eden embarks on a new chapter with the launch of Eden Portal. This innovative platform transforms the way patients interact with their institutions and their medical information.

‍

A portal designed for patients

Eden Portal offers a simple and intuitive user experience accessible from any mobile device. Patients can access their complete medical history, including images, reports, and specialty studies, all in one place.

‍

Advanced tools for doctors

Eden Portal benefits patients and empowers doctors with advanced tools to make more accurate and efficient diagnoses. Doctors can perform MPRs, curved reconstructions, and vessel analysis with 3D reconstruction, all from the comfort of their smartphones.

‍

Top-notch security and privacy

Eden Portal is ISO 27001 certified, the highest cybersecurity guarantee in the medical industry. The platform also offers password options for enhanced privacy and data protection.

‍

The future of healthcare

With the launch of Eden Portal, Eden takes a significant step towards its vision of a future without deadly diseases. The company is committed to working with its partners to transform healthcare and provide a better experience for patients and doctors worldwide.

‍